Becton, Dickinson and Company (NYSE:BDX) Receives $279.50 Consensus Price Target from Brokerages
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price […]
More Stories
Sysco (NYSE:SYY) Price Target Raised to $88.00
Sysco (NYSE:SYY – Free Report) had its price target increased by JPMorgan Chase & Co. from $85.00 to $88.00 in...
Trio-Tech International (NYSE:TRT) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Trio-Tech International (NYSE:TRT – Free Report) in a research report released on Monday morning....
SL Green Realty (NYSE:SLG) Upgraded to “Inline” by Evercore ISI
Evercore ISI upgraded shares of SL Green Realty (NYSE:SLG – Free Report) from an underperform rating to an inline rating...
StockNews.com Upgrades Trade Desk (NASDAQ:TTD) to “Buy”
StockNews.com upgraded shares of Trade Desk (NASDAQ:TTD – Free Report) from a hold rating to a buy rating in a...
Morgan Stanley Trims Range Resources (NYSE:RRC) Target Price to $31.00
Range Resources (NYSE:RRC – Free Report) had its price objective decreased by Morgan Stanley from $33.00 to $31.00 in a...
Intra-Cellular Therapies (NASDAQ:ITCI) Earns Overweight Rating from Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Free Report) in a research report report...